|Clinical pharmacokinetics of metformin|
GG Graham, J Punt, M Arora, RO Day, MP Doogue, J Duong, TJ Furlong, ...
Clinical pharmacokinetics 50 (2), 81-98, 2011
|Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children—a meta-analysis|
JF Roos, J Doust, SE Tett, CMJ Kirkpatrick
Clinical biochemistry 40 (5-6), 383-391, 2007
|Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and …|
JA Roberts, CMJ Kirkpatrick, MS Roberts, TA Robertson, AJ Dalley, ...
Journal of antimicrobial chemotherapy 64 (1), 142-150, 2009
|Prevalence and factors associated with polypharmacy in long-term care facilities: a systematic review|
N Jokanovic, ECK Tan, MJ Dooley, CM Kirkpatrick, JS Bell
Journal of the American Medical Directors Association 16 (6), 535. e1-535. e12, 2015
|Dosing in obesity: a simple solution to a big problem|
PY Han, SB Duffull, CMJ Kirkpatrick, B Green
Clinical Pharmacology & Therapeutics 82 (5), 505-508, 2007
|Resveratrol does not benefit patients with nonalcoholic fatty liver disease|
VS Chachay, GA Macdonald, JH Martin, JP Whitehead, ...
Clinical Gastroenterology and Hepatology 12 (12), 2092-2103. e6, 2014
|Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram|
A Chan, GK Isbister, CMJ Kirkpatrick, SB Dufful
QJM: An International Journal of Medicine 100 (10), 609-615, 2007
|First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis|
JA Roberts, CMJ Kirkpatrick, MS Roberts, AJ Dalley, J Lipman
International journal of antimicrobial agents 35 (2), 156-163, 2010
|The therapeutic monitoring of antimicrobial agents|
EJ Begg, ML Barclay, CMJ Kirkpatrick
British Journal of Clinical Pharmacology 52 (S1), 35-43, 2001
|Pharmacist-led medication review in community settings: An overview of systematic reviews|
N Jokanovic, ECK Tan, S Sudhakaran, CM Kirkpatrick, MJ Dooley, ...
Research in Social and Administrative Pharmacy 13 (4), 661-685, 2017
|Resveratrol–pills to replace a healthy diet?|
VS Chachay, CMJ Kirkpatrick, IJ Hickman, M Ferguson, JB Prins, ...
British journal of clinical pharmacology 72 (1), 27-38, 2011
|Once daily aminoglycoside therapy|
ML Barclay, CMJ Kirkpatrick, EJ Begg
Clinical pharmacokinetics 36 (2), 89-98, 1999
|The relationship between drug clearance and body size|
SC McLeay, GA Morrish, CMJ Kirkpatrick, B Green
Clinical pharmacokinetics 51 (5), 319-330, 2012
|Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia|
BA Atcheson, PJ Taylor, CMJ Kirkpatrick, SB Duffull, DW Mudge, ...
Therapeutic drug monitoring 26 (3), 284-286, 2004
|Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patients|
JA Roberts, CMJ Kirkpatrick, J Lipman
Journal of Antimicrobial Chemotherapy 66 (2), 227-231, 2011
|Population pharmacokinetics of intravenous, intramuscular, and intranasal naloxone in human volunteers|
J Dowling, GK Isbister, CMJ Kirkpatrick, D Naidoo, A Graudins
Therapeutic drug monitoring 30 (4), 490-496, 2008
|Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep|
MT Rademaker, CJ Charles, EA Espiner, S Fisher, CM Frampton, ...
Journal of the American College of Cardiology 40 (8), 1495-1505, 2002
|Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function|
JK Duong, SS Kumar, CM Kirkpatrick, LC Greenup, M Arora, TC Lee, ...
Clinical pharmacokinetics 52 (5), 373-384, 2013
|Rapid and simple high-performance liquid chromatographic assay for the determination of metformin in human plasma and breast milk|
M Zhang, GA Moore, M Lever, SJ Gardiner, CMJ Kirkpatrick, EJ Begg
Journal of Chromatography B 766 (1), 175-179, 2002
|A standard weight descriptor for dose adjustment in the obese patient|
SB Duffull, MJ Dooley, B Green, SG Poole, CMJ Kirkpatrick
Clinical pharmacokinetics 43 (15), 1167-1178, 2004